MicroRNA‐425‐3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma

E-ISSN： 1478-3231|35|3|1077-1086

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.3, 2015-03, pp. : 1077-1086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fever within 2 Weeks of Sorafenib Therapy Predicts Favorable Treatment Efficacy in Patients with Advanced Hepatocellular Carcinoma

Oncology, Vol. 91, Iss. 5, 2016-09 ,pp. : 261-266

Karger

Access to resources Recommend Favorite

Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks

HEPATOLOGY RESEARCH, Vol. 48, Iss. 1, 2018-01 ,pp. : 5-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early Decrease in α-Fetoprotein, but Not Des-γ-Carboxy Prothrombin, Predicts Sorafenib Efficacy in Patients with Advanced Hepatocellular Carcinoma

Oncology, Vol. 81, Iss. 3-4, 2011-11 ,pp. : 251-258

Karger

Access to resources Recommend Favorite

Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 1024-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite

microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma

By Zhu Xu-Chao Dong Qiong-Zhu Zhang Xiao-Fei Deng Biao Jia Hu-Liang Ye Qin-Hai Qin Lun-Xiu Wu Xing-Zhong

International Journal of Molecular Medicine, Vol. 30, Iss. 6, 2012-12 ,pp. : 1321-1326

Spandidos Publications

Access to resources Recommend Favorite